Impact of the Use of Benznidazole Followed by Antioxidant Supplementation in the Prevalence of Ventricular Arrhythmias in Patients With Chronic Chagas Disease: Pilot Study

No abstract is available for this paper.

• Publication year

  2016

• Venue

  American Journal of Therapeutics

• Publication date

  2016-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MJT.0000000000000137PMID 25461962
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• American Trypanosomiasis Chagas Disease

  2017cited by this paper
• Chagas disease: an overview of clinical and epidemiological aspects.

  2013cited by this paper
• American trypanosomiasis (Chagas disease).

  2012cited by this paper
• Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.

  2012cited by this paper
• Effect of oxidative stress on ventricular arrhythmia in rabbits with adriamycin-induced cardiomyopathy

  2012cited by this paper
• Cost-benefit of the telecardiology service in the state of Minas Gerais: Minas Telecardio Project.

  2011cited by this paper
• Update in treatment of Chagas disease

  2011cited by this paper
• I Diretriz Latino-Americana para o Diagnóstico e Tratamento da Cardiopatia Chagásica

  2011cited by this paper
• I Latin American guidelines for the diagnosis and treatment of Chagas cardiomyopathy

  2011cited by this paper
• [I Latin American guidelines for the diagnosis and treatment of Chagas cardiomyopathy].

  2011cited by this paper
• Chronic phase of Chagas disease: why should it be treated? A comprehensive review.

  2011cited by this paper
• Antioxidant therapy attenuates oxidative insult caused by benzonidazole in chronic Chagas' heart disease.

  2010influential reference
• Faculty Opinions recommendation of Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial.

  2008cited by this paper
• Problems and perspectives for Chagas disease control: in search of a realistic analysis.

  2008cited by this paper
• Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT).

  2008cited by this paper
• Chagas heart disease pathogenesis: one mechanism or many?

  2008influential reference
• Vitamin E regulatory mechanisms.

  2007cited by this paper
• Pathogenesis of Chronic Chagas Heart Disease

  2007cited by this paper
• Antioxidant therapy attenuates oxidative stress in chronic cardiopathy associated with Chagas' disease.

  2007influential reference
• Implantable Cardioverter‐Defibrillators in Patients with Chagas Heart Disease: Misperceptions, Many Questions and the Urgent Need for a Randomized Clinical Trial

  2007cited by this paper
• Vitamin E, antioxidant and nothing more.

  2007cited by this paper
• Regulatory role of vitamins E and C on extracellular matrix components of the vascular system.

  2007cited by this paper
• The relationship between dose of vitamin E and suppression of oxidative stress in humans.

  2007cited by this paper
• Oxidative stress in chronic cardiopathy associated with Chagas disease.

  2007influential reference
• Vitamin E deficiency enhances pathology in acute Trypanosoma cruzi-infected rats.

  2006cited by this paper
• Long-Term Cardiac Outcomes of Treating Chronic Chagas Disease with Benznidazole versus No Treatment

  2006cited by this paper
• Treatment with Benznidazole during the Chronic Phase of Experimental Chagas' Disease Decreases Cardiac Alterations

  2005cited by this paper
• Diretrizes para Avaliação e Tratamento de Pacientes com Arritmias Cardíacas

  2002cited by this paper
• I Diretriz de Dor Torácica na Sala de Emergência

  2002cited by this paper
• Control of Chagas Disease. Second Report of the WHO Expert Committee. WHO Technical Report Series, No. 905. Geneva: World Health Organization, 2002. vi + 109pp. Price Sw.fr. 23/US$20.70 (in developing countries Sw.fr.16.10). ISBN 92-4-120905.4

  2002cited by this paper
• Time-dependent oxidative stress caused by benznidazole

  2001cited by this paper
• Sudden death in Chagas' disease.

  2001cited by this paper
• Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial.

  2000cited by this paper
• Immunopathology of Chagas disease.

  1999cited by this paper
• Increased oxidative stress in patients with congestive heart failure.

  1998cited by this paper
• Increased Oxidative Stress in Patients With Congestive Heart Failure

  1998cited by this paper
• [Ventricular arrhythmia in Chagas disease. Diagnostic, prognostic, and therapeutic features].

  1995cited by this paper
• Vitamin E consumption and the risk of coronary heart disease in men.

  1993cited by this paper
• Clinical, histochemical, and ultrastructural correlation in septal endomyocardial biopsies from chronic chagasic patients: detection of early myocardial damage.

  1987cited by this paper
• Free radicals in biology and medicine

  1985influential reference

• Effects of Free and Nanoencapsulated Benznidazole in Acute Trypanosoma cruzi Infection: Role of Cholinergic Pathway and Redox Status

  2024cites this paper
• New Drugs and Promising Drug Combinations in the Treatment of Chagas Disease in Brazil: A Systematic Review and Meta-Analysis.

  2024cites this paper
• Antioxidants in Arrhythmia Treatment—Still a Controversy? A Review of Selected Clinical and Laboratory Research

  2022influential citation
• Mitigation of benznidazole toxicity and oxidative stress following ascorbic acid supplementation in an adult traveller with chronic indeterminate Chagas' disease.

  2022cites this paper
• Selenium, TGF-Beta and Infectious Endemic Cardiopathy: Lessons from Benchwork to Clinical Application in Chagas Disease

  2022cites this paper
• In vitro evaluation of Resveratrol as a potential pre-exposure prophylactic drug against Trypanosoma cruzi infection

  2022cites this paper
• Resveratrol impacts in oxidative stress in liver during Trypanosoma cruzi infection.

  2021cites this paper
• Effects of Selenium treatment on cardiac function in Chagas heart disease: Results from the STCC randomized Trial

  2021cites this paper
• Dual chemotherapy with benznidazole at suboptimal dose plus curcumin nanoparticles mitigates Trypanosoma cruzi-elicited chronic cardiomyopathy.

  2020cites this paper
• Anti-inflammatory and antioxidant therapies for chagasic myocarditis: a systematic review

  2020cites this paper
• Potential Role of Antioxidants as Adjunctive Therapy in Chagas Disease

  2020cites this paper
• Honokiol attenuates oxidative stress-dependent heart dysfunction in chronic Chagas disease by targeting AMPK / NFE2L2 / SIRT3 signaling pathway.

  2020cites this paper
• Suplementação combinadas de vitaminas C e E com objetivo de redução do risco de doenças

  2020cites this paper
• Oxidative stress in schistosomiasis, echinococcosis, and trypanosomiasis: a therapeutic approach

  2019cites this paper
• ROS and Trypanosoma cruzi: Fuel to infection, poison to the heart

  2018cites this paper
• Benefits of Ascorbic Acid in Association with Low-Dose Benznidazole in Treatment of Chagas Disease

  2018cites this paper
• Therapeutic Efficacy of a Subunit Vaccine in Controlling Chronic Trypanosoma cruzi Infection and Chagas Disease Is Enhanced by Glutathione Peroxidase Over-Expression

  2015cites this paper